TGI
TRV GP III Portfolio holdings
AUM
$6.14M
This Quarter Return
-23.61%
1 Year Return
+45.44%
3 Year Return
+169.05%
5 Year Return
+771.75%
10 Year Return
–
AUM
$573M
AUM Growth
+$573M
(-28%)
Cap. Flow
-$28.8M
Cap. Flow
% of AUM
-5.03%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Nurix Therapeutics
NRIX
|
$28.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$7.31B
| $175M | 30.61% |
5,524,031
| – | – |
|
2
Pliant Therapeutics
PLRX
$101M
| $170M | 29.69% |
5,839,160
| – | – |
|
|
3
Nurix Therapeutics
NRIX
$706M
| $90.8M | 15.85% |
3,422,549
-1,085,784
| -24% | -$28.8M |
|
4
Fulcrum Therapeutics
FULC
$349M
| $62.5M | 10.91% |
5,962,202
| – | – |
|
|
DBTX
5
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $27M | 4.71% |
3,139,685
| – | – |
|
6
Voyager Therapeutics
VYGR
$200M
| $26.4M | 4.61% |
6,391,176
| – | – |
|
|
JNCE
7
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $20.7M | 3.62% |
3,048,780
| – | – |
|